AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Generic drug price deflation and fewer expected generic-drug launches will put pressure on overall industry profits this year and next. AmerisourceBergen has been working to counter those effects by entering new markets through strategic acquisitions. This includes getting into animal health distribution with MWI Veterinary Supply, compounding with PharMEDium, and clinical trial logistics with World Courier. AmerisourceBergen also could face a windfall of new revenue in coming years after its partner Walgreens absorbs Rite Aid and its more than 4,500 pharmacists.
News about AmerisourceBergen
And the lawmakers who called for the probe now want it expanded to diabetes drugs.
But health care stocks are hot.
This year's list includes insurers, drug wholesalers, and some household names.
Deal sets the stage for even more M&A activity in outsourced pharma services sector.